Preliminary pharmacokinetic assessment of BT1718: a phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) in patients with advanced solid tumours

dc.contributor.author	Banerji, U
dc.contributor.author	Cook, Natalie
dc.contributor.author	Evans, T
dc.contributor.author	Moreno, I
dc.contributor.author	Patricia, R
dc.contributor.author	Kelly, Claire
dc.contributor.author	Sabaratnam, N
dc.contributor.author	Passi, R
dc.contributor.author	Godfrey, L
dc.contributor.author	Sawretse, L
dc.contributor.author	Katugampola, S
dc.contributor.author	Halbert, G
dc.contributor.author	Jeffrey, P
dc.contributor.author	Rigby, M
dc.contributor.author	Bennett, G
dc.contributor.author	Koehler, M
dc.contributor.author	Langford, G
dc.contributor.author	Pittman, M
dc.contributor.author	Symeonides, S
dc.date.accessioned	2019-04-29T09:49:00Z
dc.date.available	2019-04-29T09:49:00Z
dc.date.issued	2018	en
dc.identifier.citation	Banerji U, Cook N, Evans T, Moreno I, Patricia R, Kelly C, et al. Preliminary pharmacokinetic assessment of BT1718: a phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) in patients with advanced solid tumours. Eur J Cancer. 2018;103:E65.	en
dc.identifier.uri	http://hdl.handle.net/10541/621796
dc.language.iso	en	en
dc.title	Preliminary pharmacokinetic assessment of BT1718: a phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) in patients with advanced solid tumours	en
dc.type	Meetings and Proceedings	en
dc.contributor.department	The Institute of Cancer Research, London, and the Royal Marsden NHS Foundation Trust., Drug Development Unit, Sutton	en
dc.identifier.journal	European Journal of Cancer	en
dc.description.note		en]